Articles From: EP Energy Provides Operational Update - Increases Wolfcamp Type Well EUR and Economics to EPIRUS to Present at Wedbush Life Sciences Management Access Conference


2014/7/31
HOUSTON , July 31, 2014 /PRNewswire/ -- EP Energy Corporation (NYSE:EPE, "EP Energy") today provided an update on its growing oil programs.
Sign-up for EP Energy Provides Operational Update - Increases Wolfcamp Type Well EUR and Economics investment picks
HOUSTON , Sept.
Sign-up for EP Energy's CFO to Present at Deutsche Bank Finance Conference investment picks
PNM Resources' (NYSE: PNM) New Mexico utility, PNM, praised Friday’s decision by the U.S. Environmental Protection Agency (EPA) approving a revised state plan to comply with federal environmental rules that calls for closing two of four units at the San Juan Generating Station, a coal-fired power plant located in the Four Corners area of northwestern New Mexico.
Sign-up for EPA Approves Revised State Plan for PNM’s San Juan Generating Station investment picks
DAVIS, Calif., July 8, 2014 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII) , a leading global provider of bio-based pest management and plant health products announced today that the U.S. Environmental Protection Agency (EPA) has approved Zequanox for open water use to combat invasive zebra and quagga mussels in lakes, rivers, recreation areas and other open bodies of water.
Sign-up for EPA Approves Zequanox(R) for Invasive Mussel Control in Open Water investment picks
ANGUS Chemical Company today announced that AMP, a multifunctional specialty chemical that’s widely used in latex paint formulations, is no longer classified as a volatile organic compound (VOC) under a final rule by the U.S. Environmental Protection Agency.
Sign-up for EPA Grants VOC-Exempt Status to ANGUS’ AMP Multifunctional Paint Additive investment picks
LONDON, Aug.
Sign-up for epay Partners With Appflare to Launch Beacon Network investment picks
2014/9/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147222&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Epazz Files First-Quarter 10-Q: Reports 21 Percent Increase in Revenues for First Quarter of 2014; Second-Quarter 10-Q in Process of Being Finalized investment picks
2014/10/2
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1148861&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Epazz Files Second-Quarter 10-Q: Reports 17 Percent Increase in Revenues for Second Quarter of 2014; Epazz Is Now Current investment picks
2014/10/3
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1149123&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Epazz Has Completed Acquisition of Cynergy; Epazz Expects to Add 15% to Recurring Revenue Stream investment picks
2014/9/26
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147457&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Epazz Signed Purchase Agreement to Acquire Surveillance Software Company; Epazz Expects to Add Over $300,000 to Revenue Stream investment picks
Yovo takes ephemerality beyond just photo sharing with enhanced privacy tools that scramble screenshots and enable sharing across Facebook, Twitter, text and e-mail PLANO, Texas , Oct.
Sign-up for Ephemeral Photos And Messages Get More Private, Interactive And Fun With Yovo From ContentGuard investment picks
2014/9/2
Pilots no longer need a wallet full of charge-card options when traveling domestically or internationally.
Sign-up for EPIC and U.S. Bank Multi Service Aviation Network Announce Global Card Acceptance investment picks
2014/8/7
http://media.marketwire.com/attachments/201011/5080_LOGOEPICCORP.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1136172&ProfileId=051205&sourceType=1 AUSTIN, TX --
Sign-up for EPIC Enters a Marketing and Sales Joint Venture, and Files a 15c2-11 to Trade Its Preferred Stock investment picks
2014/9/18
By Ben Eisen, MarketWatch NEW YORK (MarketWatch) -- Shares of EPIQ Systems surged Thursday after an activist investor said it took a stake in the company.
Sign-up for EPIQ surges on activist stake; Rite Aid sinks investment picks
KANSAS CITY, Kan., Aug.
Sign-up for Epiq Systems Announces Appointment of Douglas M. Gaston to Its Board of Directors investment picks
KANSAS CITY, Kan., July 31, 2014 (GLOBE NEWSWIRE) -- Epiq Systems, Inc. (Nasdaq:EPIQ) today announced results for the second quarter of 2014 with operating revenue of $115.5 million, up 10% compared to $105.0 million for the prior year quarter.
Sign-up for Epiq Systems Announces Second Quarter 2014 Financial Results in Line With Expectations investment picks
KANSAS CITY, Kan., Sept.
Sign-up for Epiq Systems Issues Statement Regarding Recent Schedule 13D Filings investment picks
KANSAS CITY, Kan., Aug.
Sign-up for Epiq Systems Names Jig Patel as Vice President of Information Technology investment picks
KANSAS CITY, Kan., Oct.
Sign-up for Epiq Systems Retains Credit Suisse to Assist Board in Review of Strategic Alternatives investment picks
KANSAS CITY, Kan., July 15, 2014 (GLOBE NEWSWIRE) -- Epiq Systems, Inc. (Nasdaq:EPIQ) will report financial results for the second quarter ended June 30, 2014 after the close of the market on Thursday, July 31, 2014.
Sign-up for Epiq Systems Second Quarter 2014 Earnings Results to be Announced July 31, 2014 investment picks
NEW YORK, June 24, 2014 (GLOBE NEWSWIRE) -- Epiq Systems, Inc. (Nasdaq:EPIQ) , a leading provider of managed technology for the global legal profession, today announced that David Rohde, senior director of consulting services, has earned an Information Governance Professional (IGP) certification.
Sign-up for Epiq Systems Senior Director David Rohde Earns Information Governance Professional Certification investment picks
KANSAS CITY, Kan., July 29, 2014 (GLOBE NEWSWIRE) -- Epiq Systems, Inc. (Nasdaq:EPIQ) , a leading provider of managed technology for the global legal profession, today announced that Tom W.
Sign-up for Epiq Systems to Present at the Needham Interconnect Conference on August 5 investment picks
2014/9/25
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS ), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, announced today that it has signed a royalty-bearing, multi-product collaboration agreement with Livzon Mabpharm Inc. (Livzon), a Chinese biotechnology company focused on the development, manufacture, and sale of antibody-based drugs.
Sign-up for EPIRUS and Livzon Mabpharm, Inc. Enter Collaboration Agreement for China investment picks
2014/9/23
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS ), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced positive 58 week follow up data from its BOW015 efficacy and safety trial comparing BOW015, a biosimilar infliximab, to Remicade.
Sign-up for EPIRUS Announces Positive 58 Week Follow up Data for BOW015 for Treatment of Rheumatoid Arthritis investment picks
2014/9/22
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS ), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced that the company will present at the NewsMakers in the Biotech Industry conference at 2:30 PM EDT, Friday, September 26, at the Millennium Broadway Hotel in New York City.
Sign-up for EPIRUS to Present at NewsMakers in the Biotech Industry Conference investment picks
2014/8/7
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ:EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced that the company will present at the Wedbush Life Sciences Management Access Conference at 4:15 p.m. EDT, Tuesday, Aug.
Sign-up for EPIRUS to Present at Wedbush Life Sciences Management Access Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: EP Energy Provides Operational Update - Increases Wolfcamp Type Well EUR and Economics to EPIRUS to Present at Wedbush Life Sciences Management Access Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices